Boston Scientific (BSX) Current Deferred Tax Assets (2009 - 2019)

Boston Scientific has disclosed Current Deferred Tax Assets across 11 years of filings, most recently posting $4.2 billion for Q4 2019.

• In Q4 2019, Current Deferred Tax Assets rose 2506.21% year-over-year to $4.2 billion; the TTM figure through Dec 2019 stood at $4.2 billion (up 2506.21% YoY), while the FY2019 annual figure was $4.2 billion, up 2506.21% from the prior year.
• Current Deferred Tax Assets came in at $4.2 billion for Q4 2019 at Boston Scientific, up from $189.0 million in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of $4.2 billion in Q4 2019 to a low of $43.0 million in Q3 2018.
• Average Current Deferred Tax Assets over 5 years is $356.8 million, with a median of $81.0 million recorded in 2016.
• Year-over-year, Current Deferred Tax Assets slumped 84.88% in 2016 and soared 2506.21% in 2019.
• Over 5 years, Current Deferred Tax Assets stood at $496.0 million in 2015, then tumbled by 84.88% to $75.0 million in 2016, then dropped by 12.0% to $66.0 million in 2017, then surged by 143.94% to $161.0 million in 2018, then soared by 2506.21% to $4.2 billion in 2019.
• Per Business Quant data, the three most recent Current Deferred Tax Assets figures were $4.2 billion in Q4 2019, $189.0 million in Q3 2019, and $175.0 million in Q2 2019.